Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Qlife will not respond to preliminary rejection by the Danish Medicines Agency for COVID-19 test – focus on receiving CE-marking by year-end

Qlife has decided not to respond to the preliminary announcement from the Danish Medicines Agency (Lægemiddelstyrelsen) regarding the rejection of the company’s application for temporay approval in Denamark “in the interest of health protection” for the company’s COVID-19 test. The company will instead focus on completing the documentation for CE-marking in accordance with the timeline previously communicated. Qlife expects CE-marking at the turn of the year 2020/2021.On November 13, Qlife was informed that the Danish Medicines Agency (Lægemiddelstyrelsen) had rejected the application for

Bittium Corporation’s Strategy and Long-Term Financial Targets

Stock Exchange Release Free for publication on November 27, 2020 at 2.47 p.m. (CET+1) Bittium Corporation’s Strategy and Long-Term Financial Targets Bittium aims to be a significant global provider of secure and safe communication solutions in the defense and public safety markets, and a leading provider of connectivity solutions and R&D services for different industries, as well as a significant provider of remote measuring and diagnostics solutions for measuring and analyzing biosignals. Five years ago, Bittium Corporation updated its strategy in order to strengthen its position

Bittium Corporation’s Board of Directors Has Decided That No Dividend Will Be Paid for 2019

Stock Exchange Release Free for publication on November 27, 2020 at 2.46 p.m. (CET+1) Bittium Corporation’s Board of Directors Has Decided That No Dividend Will Be Paid for 2019 Under the authorization of the Annual General Meeting held on June 15, 2020, the Board of Directors of Bittium Corporation has decided today, that no dividend based on the distributable assets of the adopted balance sheet for the financial period of January 1, 2019 - December 31, 2019 shall be paid. This decision strengthens the company’s ability to invest in line with its strategy to enable future growth.

Bittium Corporation Lowers Its Financial Outlook for 2020

Stock Exchange Release Free for publication on November 27, 2020 at 2.45 p.m. (CET+1) Bittium Corporation Lowers Its Financial Outlook for 2020 Bittium Corporation lowers its financial outlook for 2020. The company expects that the net sales in 2020 will be at the same level or grow from the previous year (EUR 75.2 million in 2019), and the operating result will be lower than in the previous year (EUR 6.3 million in 2019). Earlier, Bittium expected that the net sales in 2020 will grow from the previous year (EUR 75.2 million in 2019) and the operating result will be at the same

SAPA launches sliding door using extremely slim profiles

SAPA is now launching a sleek, high-quality lift-and-slide door that elegantly combines slim profiles with a high level of airtightness and excellent thermal properties. The most important feature of this design is also the least visible: its narrow centre profile. These slim profiles allow a minimalist design approach and let in even more of that all-important daylight.   Minimalist design adapted for the Nordic climate    The construction is based on the classic 2160S door, using extra-slim profiles to create 2160S XS. The sliding door is fabricated from insulating aluminium

Report from Epiroc AB’s Extraordinary General Meeting

Stockholm, Sweden: Epiroc AB’s Extraordinary General Meeting (EGM) held today approved the proposed second dividend of SEK 1.20 per share.The record date will be December 1, 2020, and the second dividend is expected to be distributed by Euroclear Sweden AB on December 4, 2020.  The EGM also approved the proposals to amend Epiroc AB’s articles of association so that the Board of Directors ahead of future General Meetings is able to decide on the collection of proxy votes and the opportunity for voting by mail. Due to the Covid-19 pandemic and the related restrictions, and in accordance

Inzile delivers four electric trucks to Bring for fossil-free home deliveries starting on Black Friday

Inzile delivers four electric trucks to Bring of the new model Pro4 Max. The first Inzile vehicle was delivered in June this year and has worked out well in Bring's operations. The four new electric vehicles will also be used for fossil-free home deliveries in urban environments.The four light trucks delivered from Inzile are the continuation of the collaboration with Bring, which began with the delivery of a first electric truck in June this year. Posten Norge, of which Bring is a part, owns about five percent of Inzile. Bring has so far ordered five trucks from Inzile. Inzile and Bring

NPRO: Approval and publication of prospectus

NOT FOR DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL   Reference is made to the stock exchange announcement from Norwegian Property ASA (the "Company") on 23 August 2020, regarding key information relating to a potential subsequent offering, and 9 November 2020 regarding completion of the NOK 557 million private placement. The

Vestas wins 40 MW order in Poland

News release from Vestas Northern and Central EuropeHamburg, 27 November 2020 Vestas has secured a 40 MW order for the Nowy Tomysl project from SPV Sevivon Windpark 2 Sp. Z.o.o., a subsidiary of leading European project developer PNE AG. Located in Kuslin in western Poland, the project will consist of 12 V126-3.45 MW wind turbines in 3.3 MW operating mode combined with 137m towers, maximising power production while at the same time offering competitive levelised cost of energy. Adding to the more than 1.5 GW of contracts signed in Poland’s auction system to date, this order

Asetek - Share Capital Increase Upon Exercise of Warrants

Reference is made to warrants issued by Asetek A/S, Danish central business register (CVR) no. 34880522 (the "Company"), pursuant to corporate resolutions adopted on August 12, 2014, August 11, 2015, April 28, 2016, and April 25, 2017 respectively. Pursuant to the applicable warrant terms, the warrants are exercisable in exercise windows open in a four weeks period running from the Company's preliminary announcement of its financial statements or publication of its interim financial report however no later than 7 years after the Subscription Date as specified in the Subscription

Sedana Medical submits market approval application for the drug Sedaconda

Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced that the company has submitted an application for market approval for the drug candidate Sedaconda (isoflurane), formerly known as IsoConDa, for inhaled sedation in intensive care. The application has been submitted to the German Medicines Agency BfArM and a number of other European Medicines Agencies through a so-called DCP procedure.The application is the starting point of the review process of Sedaconda in 15 of the EU member states, including Norway. If all goes well, Sedana Medical expects an approval in the second half of

Innovations for a better future: Fazer’s xylitol factory awarded the Finnish Star Act 2020

Fazer is The Food Experience Company, and by investing in innovations and Foodtech, Fazer strengthens its focus on the sustainable food solutions of the future. Fazer’s strategic focus on innovations has been recognised by the Finnish Food and Drink Industries’ Federation, which awarded Fazer’s xylitol factory as Star Act 2020 (Tähtiteko) on 27 November.  Innovations at the core of Fazer’s strategy  Sustainability in food and nutrition is high on Fazer’s agenda, and Fazer sees innovations as a key enabler in executing its strategy.“We see food as a solution. How we grow, produce and

Introduction of RayIntelligence and the latest releases of RayStation and RayCare at ESTRO 2020

RaySearch Laboratories AB (publ) will reveal its latest advances in oncology software at ESTRO 2020 from November 28 through December 1, 2020. Attendees can book personal online demos of treatment planning system RayStation®* and oncology information system RayCare®*. Cloud-based oncology analytics system RayIntelligence® will be presented during RaySearch Digital Satellite Symposia. The latest release of RayStation, 10B, is expected in December 2020. New functionalities in the release now include support for brachytherapy planning with automatic channel reconstruction and

Correction to the Qt Group Plc's Annual General Meeting material publication date on the company's website

Stock Exchange Release November 27, 2020 at 1 pm The stock exchange release published by Qt Group Plc on November 24, 2020 incorrectly states that "The AGM material will be available on the company's website at www.qt.io on February 17, 2021." The correct date for the material's release will be February 18, 2021. Therefore, the material related to the Annual General Meeting will be available on the company's website www.qt.io as of February 18, 2021.    DISTRIBUTIONNasdaq HelsinkiPrincipal mediawww.qt.io

Sinch AB (publ): Resolutions from the Extraordinary General Meeting in Sinch AB (publ)

Stockholm, Sweden – Sinch AB (publ) – XSTO: SINCH Sinch held an extraordinary general meeting on Friday 27 November 2020. The meeting resolved, in accordance with the board of directors’ proposal, to adopt an additional long term incentive program for senior executives and key employees within the Sinch group (“LTI II 2020”). LTI II 2020 comprises four series of warrants. Upon exercise of all warrants in LTI II 2020, up to 470,260 shares may be issued, equivalent to a maximum dilution of approximately 0.78 per cent of the shares and votes of the company. Upon full exercise of the

BAKKAFROST: Share Savings Plan Transaction

As a part of the share savings plan for employees in 2020, the following primary insiders have purchased Bakkafrost shares: · Regin Jacobsen, CEO, purchased 49 shares. After the transaction, he holds 4,616,729 shares. · Odd Eliasen, Managing Director, purchased 39 shares. After the transaction, he holds 184,458 shares. · Høgni Dahl Jakobsen, CFO, purchased 31 shares. After the transaction, he holds directly and indirectly 384 shares. · Annika Frederiksberg, Board Member, purchased 14 shares. After the transaction, she holds directly and indirectly 16,056 shares. The shares

Beijer Ref continues to invest in green technology

The investment in the Danish refrigeration technology company Fenagy A/S means that Beijer Ref is growing in the OEM segment on the European market.Beijer Ref AB (publ) has today entered into an agreement to invest in the Danish refrigeration technology company Fenagy A/S. The company is recently established and is developing and launching a new industrial product range in industrial heat pumps and cooling systems based on the environmentally friendly refrigerant CO2. Fenagy has ten employees and is headquartered in Aarhus, Denmark. Beijer Ref becomes a minority owner in the company with

Glaston Oyj Abp - Managers' Transactions

Glaston Corporation     Stock Exchange Release, Managers' Transactions 27.11.2020 at 12.00Glaston Oyj Abp - Managers' Transactions____________________________________________ Person subject to the notification requirementName: Reinikkala, Veli-MattiPosition: Member of the Board/Deputy memberIssuer: Glaston Oyj AbpLEI: 743700V3I7CLI3DJ8L62 Notification type: INITIAL NOTIFICATIONReference number: 743700V3I7CLI3DJ8L62_20201127084746_2____________________________________________ Transaction date: 2020-11-25Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN:

Cessatech’s IPO of units significantly oversubscribed

The subscription period in Cessatech A/S ("Cessatech" or the “Company”) IPO of units (shares and consideration free warrants) ended on 24 November 2020. The initial part of the IPO of units was subscribed to a total of approx. DKK 107 million, corresponding to a subscription ratio of approx. 680 percent, and Cessatech will thereby be provided approx. DKK 15.8 million (before issue costs). Through the IPO of units, Cessatech receives approx. 1,270 new shareholders. Settlement notes are scheduled to be sent out today, 27 November 2020. The first day of trading at Spotlight Stock Market is

How Covid-19 affects your shipment – second time around

Sweden is facing its second wave of COVID-19 and companies are bracing themselves wondering how it will turn out the second time around. What experience can be drawn from the past year and how will your shipments be affected? – The transition that took two weeks is now being implemented in a matter of days. In some cases hours. Our clients can be assured that we are in a good position to face the challenge the second time around, says Oscar Törnqvist, CEO of InterEast.COVERED IN THE ARTICLE:Borders and Delays – What the past months taught us and what we expect to happen Suppliers –

Shareholders’ Nomination Board of Fellow Finance

FELLOW FINANCE PLC COMPANY ANNOUNCEMENT 27.11.2020 AT 11:45 AMThe Shareholders’ Nomination Board of Fellow Finance prepares proposals for the Annual General Meeting and, if necessary, for the Extraordinary General Meeting, concerning the election and remuneration of the members of the Board of Directors. According to the procedure of the Nomination Board of Shareholders, each of the four largest shareholders of Fellow Finance appoint a member to the Nomination Board of Shareholder. Being entitled to appoint a member is based on Fellow Finance Shareholder Register maintained by Euroclear

BioStock: Chordate Medical publishes interim report and looks forward

At the end of last week, Chordate Medical published their results for the first nine months of 2020. The report shows that the company’s sales and operations have been affected by the pandemic, but despite this, Chordate Medical has high confidence going forward. The company’s financial position has recently been strengthened by two successful capital raises. In addition, a CE mark is waiting around the corner which enables start of sales within a new indication with great potential – chronic migraine.Read the full article at biostock.se: https://www.biostock.se/en/chordate-medical-

There are no items matching the current filter
There are no more items matching the current filter
Back to top